Manufacturer
Gilead Sciences
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 49
- Molecules
- 25
- Therapy areas
- 7
Gilead Sciences is a pharmaceutical manufacturer based in United States. MedsAcross lists 49 of its products across 25 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Gilead Sciences, Inc, Gilead Sciences, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Gilead Sciences products through licensed channels, with the documents your regulator needs.
HIV
32 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Biktarvy 30 mg/120 mg/15 mg tabletOral | Bictegravir, Emtricitabine and Tenofovir alafenamide | US FDA | Available on request |
| Biktarvy 50 mg/200 mg/25 mg tabletOral | Bictegravir, Emtricitabine and Tenofovir alafenamide | US FDA | Available on request |
| Complera 200 mg/25 mg/300 mg tabletOral | Emtricitabine, Rilpivirine and Tenofovir disoproxil | US FDA | Available on request |
| Descovy 120 mg/15 mg tabletOral | Emtricitabine and Tenofovir alafenamide | US FDA | Available on request |
| Descovy 200 mg/25 mg tabletOral | Emtricitabine and Tenofovir alafenamide | US FDA | Available on request |
| Emtriva 10 mg/mL oral solutionOral Cold chain | Emtricitabine | US FDA | Available on request |
| Emtriva 200 mg capsuleOral Cold chain | Emtricitabine | US FDA | Available on request |
| Genvoya 150 mg/150 mg/200 mg/10 mg tabletOral | Cobicistat, Elvitegravir, Emtricitabine and Tenofovir alafenamide | US FDA | Available on request |
| Harvoni 33.75 mg/150 mg oral pelletsOral | Ledipasvir and Sofosbuvir | US FDA | Available on request |
| Harvoni 45 mg/200 mg tabletOral | Ledipasvir and Sofosbuvir | US FDA | Available on request |
| Harvoni 45 mg/200 mg oral pelletsOral | Ledipasvir and Sofosbuvir | US FDA | Available on request |
| Harvoni 90 mg/400 mg tabletOral | Ledipasvir and Sofosbuvir | US FDA | Available on request |
| Odefsey 200 mg/25 mg/25 mg tabletOral | Emtricitabine, Rilpivirine and Tenofovir alafenamide | US FDA | Available on request |
| Sovaldi 150 mg oral pelletsOral | Sofosbuvir | US FDA | Available on request |
| Sovaldi 200 mg oral pelletsOral | Sofosbuvir | US FDA | Available on request |
| Sovaldi 200 mg tabletOral | Sofosbuvir | US FDA | Available on request |
| Sovaldi 400 mg tabletOral | Sofosbuvir | US FDA | Available on request |
| Stribild 150 mg/150 mg/200 mg/300 mg tabletOral | Cobicistat, Elvitegravir, Emtricitabine and Tenofovir disoproxil | US FDA | Available on request |
| Sunlenca kit | Lenacapavir | US FDA | Available on request |
| Sunlenca 300 mg tabletOral | Lenacapavir | US FDA | Available on request |
| Truvada 100 mg/150 mg tabletOral | Emtricitabine and Tenofovir disoproxil | US FDA | Available on request |
| Truvada 133 mg/200 mg tabletOral | Emtricitabine and Tenofovir disoproxil | US FDA | Available on request |
| Truvada 167 mg/250 mg tabletOral | Emtricitabine and Tenofovir disoproxil | US FDA | Available on request |
| Truvada 200 mg/300 mg tabletOral | Emtricitabine and Tenofovir disoproxil | US FDA | Available on request |
| Vemlidy 25 mg tabletOral | Tenofovir alafenamide | US FDA | Available on request |
| Viread 150 mg tabletOral | Tenofovir disoproxil | US FDA | Available on request |
| Viread 200 mg tabletOral | Tenofovir disoproxil | US FDA | Available on request |
| Viread 250 mg tabletOral | Tenofovir disoproxil | US FDA | Available on request |
| Viread 300 mg tabletOral | Tenofovir disoproxil | US FDA | Available on request |
| Viread 40 mg/g oral powderOral | Tenofovir disoproxil | US FDA | Available on request |
| Yeztugo kit | Lenacapavir | US FDA | Available on request |
| Yeztugo 300 mg tabletOral | Lenacapavir | US FDA | Available on request |
Hepatitis B and C
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Epclusa 150 mg/37.5 mg oral pelletsOral | Sofosbuvir and Velpatasvir | US FDA | Available on request |
| Epclusa 200 mg/50 mg tabletOral | Sofosbuvir and Velpatasvir | US FDA | Available on request |
| Epclusa 200 mg/50 mg oral pelletsOral | Sofosbuvir and Velpatasvir | US FDA | Available on request |
| Epclusa 400 mg/100 mg tabletOral | Sofosbuvir and Velpatasvir | US FDA | Available on request |
| Vosevi 400 mg/100 mg/100 mg tabletOral | Sofosbuvir, Velpatasvir and Voxilaprevir | US FDA | Available on request |
Oncology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Trodelvy 180 mg powder for injectionIntravenous Cold chain | Sacituzumab govitecan | US FDA | Available on request |
| Zydelig 100 mg tabletOral | Idelalisib | US FDA | Available on request |
| Zydelig 150 mg tabletOral | Idelalisib | US FDA | Available on request |
Cardiology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Letairis 10 mg tabletOral | Ambrisentan | US FDA | Available on request |
| Letairis 5 mg tabletOral | Ambrisentan | US FDA | Available on request |
Antibiotics
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cayston kit Cold chain | Aztreonam | US FDA | Available on request |
Gastroenterology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Livdelzi 10 mg capsuleOral | Seladelpar | US FDA | Available on request |
Other products
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Bixlenvo 75 mg/50 mg tabletOral | Bictegravir and Lenacapavir | US FDA | Available on request |
| Bixlenvo Sunlenca Starter Pack kit | Bictegravir/lenacapavir | US FDA | Available on request |
| Hepcludex 8.5 mg powder for injectionSubcutaneous | Bulevirtide | US FDA | Available on request |
| Tybost 150 mg tabletOral | Cobicistat | US FDA | Available on request |
Molecules made
Bictegravir, Emtricitabine and Tenofovir alafenamideBictegravir and LenacapavirBictegravir/lenacapavirAztreonamEmtricitabine, Rilpivirine and Tenofovir disoproxilEmtricitabine and Tenofovir alafenamideEmtricitabineSofosbuvir and VelpatasvirCobicistat, Elvitegravir, Emtricitabine and Tenofovir alafenamideLedipasvir and SofosbuvirBulevirtideAmbrisentanSeladelparEmtricitabine, Rilpivirine and Tenofovir alafenamideSofosbuvirCobicistat, Elvitegravir, Emtricitabine and Tenofovir disoproxilLenacapavirSacituzumab govitecanEmtricitabine and Tenofovir disoproxilCobicistatRemdesivirTenofovir alafenamideTenofovir disoproxilSofosbuvir, Velpatasvir and VoxilaprevirIdelalisib
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Gilead Sciences
Send a request for any of these products. We confirm the licensed source, documents and lead time.